Gilead Sciences (GILD) Gross Profit (2009 - 2026)

Gilead Sciences (GILD) has reported Gross Profit for 18 consecutive years, with $6.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 11.52% year-over-year to $6.2 billion; the trailing twelve-month figure through Jun 2026 stood at $24.2 billion (up 6.94% YoY), and the FY2025 full-year result was $23.2 billion, up 3.14% from the prior year.
• Gross Profit climbed to $6.2 billion in Q2 2026 per GILD's latest filing, from $5.5 billion in the prior quarter.
• Across five years, Gross Profit topped out at $6.3 billion in Q4 2025 and bottomed at $4.8 billion in Q2 2022.
• Historically, Gross Profit has averaged $5.5 billion across 5 years, with a median of $5.5 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Profit increased 29.8% in 2022, then fell 16.17% in 2023.
• Over 5 years, Gross Profit stood at $6.0 billion in 2022, then dropped by 16.17% to $5.0 billion in 2023, then advanced by 19.19% to $6.0 billion in 2024, then advanced by 5.23% to $6.3 billion in 2025, then decreased by 1.22% to $6.2 billion in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $6.2 billion, $5.5 billion, and $6.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.